nach oben

International Journal of Behavioral Medicine

Erschienen in:

01.07.2019

Moderators of Cognitive Therapy and Bright Light Therapy Effects on Depressive Symptoms in Patients with Breast Cancer

verfasst von: Caroline Desautels, Josée Savard, Hans Ivers

Erschienen in: International Journal of Behavioral Medicine | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Cognitive therapy (CT) and bright light therapy (BLT) have been found to be effective to treat depressive symptoms in breast cancer patients. No study has investigated the baseline patients’ characteristics that are associated with better outcomes with CT vs. BLT in this population. This study aimed to assess, in breast cancer patients, the moderating role of eight clinical variables on the effects of CT and BLT on depressive symptoms.

Methods

This is a secondary analysis of a randomized controlled trial conducted in 59 women who received an 8-week CT or BLT and completed questionnaires evaluating depression and possible moderating variables.

Results

Patients benefited more from BLT when they had no prior history of major depressive disorder, higher depression scores on the Hospital Anxiety and Depression Scale (HADS-D) at baseline, a greater initial preference for BLT, and when they received BLT during spring or summer. Patients benefited more from CT when they had a lower initial preference for receiving CT, higher depression scores on the HADS-D, and seasonal depressive symptoms.

Conclusions

Although replication is needed, findings of this study suggest the existence of different profiles of patients more likely to benefit from CT and BLT.

Trial registration

NCT01637103 https://clinicaltrials.gov/ct2/show/NCT01637103

Kim SH, Son BH, Hwang SY, et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manag. 2008;35(6):644–55.

Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-oncology. 2014;23(2):121–30.PubMed

Linden W, Vodermaier A. Mismatch of desired versus perceived social support and associated levels of anxiety and depression in newly diagnosed cancer patients. Support Care Cancer. 2012;20(7):1449–56.PubMed

Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M. Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer. 2015;23(8):2215–24.PubMed

Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330(7493):702.PubMedPubMedCentral

Robson A, Scrutton F, Wilkinson L, Macleod F. The risk of suicide in cancer patients: a review of the literature. Psycho-oncology. 2010.

Somerset W, Stout SC, Miller AH, Musselman D. Breast cancer and depression. Oncology (Williston Park, NY). 2004;18(8):1021–34.

Donohue JM, Pincus HA. Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. PharmacoEconomics. 2007;25(1):7–24.PubMed

10.

Pirl WF, Roth AJ. Diagnosis and treatment of depression in cancer patients. Oncology (Williston Park, NY). 1999;13(9):1293–301 discussion 301–2, 305–6.

11.

Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006;94(3):372–90.PubMedPubMedCentral

12.

Beck AT, Dozois DJ. Cognitive therapy: current status and future directions. Annu Rev Med. 2011;62:397–409.PubMed

13.

Dobson KS, Hollon SD, Dimidjian S, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol. 2008;76(3):468–77.PubMedPubMedCentral

14.

Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):417–22.PubMed

15.

Jacobsen PB, Hann DM. Cognitive-behavioral interventions. In: Holland JC, editor. Psycho-Oncology. 1st ed. New York, NY: Oxford University Press; 1998. p. 717–29.

16.

Moyer A, Sohl SJ, Knapp-Oliver SK, Schneider S. Characteristics and methodological quality of 25 years of research investigating psychosocial interventions for cancer patients. Cancer Treat Rev. 2009;35(5):475–84.PubMedPubMedCentral

17.

Evans RL, Connis RT. Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Public Health Rep. 1995;110(3):306–11.PubMedPubMedCentral

18.

Edelman S, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psycho-oncology. 1999;8(4):295–305.PubMed

19.

Greer S, Moorey S, Baruch JD, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. BMJ. 1992;304(6828):675–80.PubMedPubMedCentral

20.

Hopko DR, Bell JL, Armento M, et al. Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behav Ther. 2008;39(2):126–36.PubMed

21.

Moorey S, Greer S, Watson M, et al. Adjuvant psychological therapy for patients with cancer: outcome at one year. Psycho-oncology. 1994;3(1):39–46.

22.

Qiu J, Chen W, Gao X, et al. A randomized controlled trial of group cognitive behavioral therapy for Chinese breast cancer patients with major depression. J Psychosom Obstet Gynaecol. 2013;34(2):60–7.PubMed

23.

Savard J, Simard S, Giguere I, et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects. Palliat Support Care. 2006;4(3):219–37.PubMed

24.

Goel N, Terman M, Terman JS, Macchi MM, Stewart JW. Controlled trial of bright light and negative air ions for chronic depression. Psychol Med. 2005;35:945–55.PubMed

25.

Loving RT, Kripke DF, Shuchter SR. Bright light augments antidepressant effects of medication and wake therapy. Depress Anxiety. 2002;16:1–3.PubMed

26.

Martiny K, Lunde M, Unden M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: results from clinicianrated depression scales. Acta Psychiatr Scand. 2005;112:117–25.PubMed

27.

Avery DH, Eder DN, Bolte MA, Hellekson CJ, Dunner DL, Vitiello MV, et al. Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry. 2001;50:205–16.PubMed

28.

Lam RW, Tam EM. A clinician’s guide to using light therapy. 1st ed. New York, NY: Cambridge University Press; 2009.

29.

Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectrums. 2005;10(8):647–63 quiz 72.PubMed

30.

Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin. 2008;58(4):214–30.PubMed

31.

Jeste N, Liu L, Rissling M, Trofimenko V, Natarajan L, Parker BA, et al. Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy. Qual Life Res. 2012.

32.

Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, et al. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer. 2011.

33.

Neikrug AB, Rissling M, Trofimenko V, Liu L, Natarajan L, Lawton S, et al. Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med. 2012;10(3):202–16.PubMed

34.

Redd WH, Valdimarsdottir H, Wu LM, Winkel G, Byrne EE, Beltre MA, et al. Systematic light exposure in the treatment of cancer-related fatigue: a preliminary study. Psychooncology. 2014.

35.

Wu LM, Amidi A, Valdimarsdottir H, et al. The effect of systematic light exposure on sleep in a mixed group of fatigued cancer survivors. J Clin Sleep Med. 2018;14(01):31–9.PubMedPubMedCentral

36.

Rohan KJ, Lindsey KT, Roecklein KA, Lacy TJ. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder. J Affect Disord. 2004;80(2–3):273–83.PubMed

37.

Rohan KJ, Roecklein KA, Lacy TJ, Vacek PM. Winter depression recurrence one year after cognitive-behavioral therapy, light therapy, or combination treatment. Behav Ther. 2009;40(3):225–38.PubMed

38.

Rohan KJ, Roecklein KA, Tierney Lindsey K, Johnson LG, Lippy RD, Lacy TJ, et al. A randomized controlled trial of cognitive-behavioral therapy, light therapy, and their combination for seasonal affective disorder. J Consult Clin Psychol. 2007;75(3):489–500.PubMed

39.

Desautels C, Savard J, Ivers H, Caplette-Gingras A. Treatment of depressive symptoms in patients with breast cancer: A randomized controlled trial comparing cognitive therapy and bright light therapy. Health Psychol. 2018;37(1):1-13.

40.

Meyerhoff J, Rohan KJ. Treatment expectations for cognitive-behavioral therapy and light therapy for seasonal affective disorder: change across treatment and relation to outcome. J Consult Clin Psychol. 2016;84(10):898–906.PubMedPubMedCentral

41.

Kwan BM, Dimidjian S, Rizvi SL. Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther. 2010;48(8):799–804.PubMedPubMedCentral

42.

Mergl R, Henkel V, Allgaier AK, Kramer D, Hautzinger M, Kohnen R, et al. Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients’ choice arm. Psychother Psychosom. 2011;80(1):39–47.PubMed

43.

De Graaf LE, Hollon SD, Huibers MJ. Predicting outcome in computerized cognitive behavioral therapy for depression in primary care: a randomized trial. J Consult Clin Psychol. 2010;78(2):184–9.PubMed

44.

Driessen E, Cuijpers P, Hollon SD, Dekker JJ. Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? A meta-analysis. J Consult Clin Psychol. 2010;78(5):668–80.PubMed

45.

Hoifodt RS, Mittner M, Lillevoll K, Katla SK, Kolstrup N, Eisemann M, et al. Predictors of response to web-based cognitive behavioral therapy with high-intensity face-to-face therapist guidance for depression: a Bayesian analysis. JMIR. 2015;17(9):e197.PubMed

46.

Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, et al. Baseline depression severity as moderator of depression outcomes between cognitive behavioral therapy vs pharmacotherapy: an individual patient data meta-analysis. JAMA Psychiatry. 2015;72(11):1102–9.PubMed

47.

Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656–62.PubMed

48.

Martensson B, Pettersson A, Berglund L, Ekselius L. Bright white light therapy in depression: a critical review of the evidence. J Affect Disord. 2015;182:1–7.PubMed

49.

Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.PubMed

50.

Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev (Online). 2004;2:CD004050.

51.

Lam RW. Morning light therapy for winter depression: predictors of response. Acta Psychiatr Scand. 1994;89(2):97–101.PubMed

52.

Privitera MR, Moynihan J, Tang W, Khan A. Light therapy for seasonal affective disorder in a clinical office setting. J Psychiatr Pract. 2010;16(6):387–93.PubMedPubMedCentral

53.

Naus T, Burger A, Malkoc A, Molendijk M, Haffmans J. Is there a difference in clinical efficacy of bright light therapy for different types of depression? A pilot study. J Affect Disord. 2013;151(3):1135–7.PubMed

54.

Thalén BE, Kjellman BF, Mørkrid L, Wibom R, Wetterberg L. Light treatment in seasonal and nonseasonal depression. Acta Psychiatr Scand. 1995;91(5):352–60.PubMed

55.

Even C, Schroder CM, Friedman S, Rouillon F. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord. 2008;108(1–2):11–23.PubMed

56.

Reichborn-Kjennerud T, Lingjaerde O. Response to light therapy in seasonal affective disorder: personality disorders and temperament as predictors of outcome. J Affect Disord. 1996;41(2):101–10.PubMed

57.

Savard J, Laberge B, Gauthier JG, Ivers H, Bergeron MG. Evaluating anxiety and depression in HIV-infected patients. J Pers Assess. 1998;71:349–67.PubMed

58.

Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.

59.

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.

60.

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

61.

Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82(10):1904–8.PubMed

62.

Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry. 1972;3:257–60.

63.

First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders - patient edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996.

64.

Williams JBW, Link MJ, Rosenthal NE, Amira L, Terman M. Structured interview guide for the hamilton depression rating scale-seasonal affective disorder version (SIGH-SAD). New York: New York State Psychiatric Institute; 1992.

65.

Donofry SD, Roecklein KA, Rohan KJ, Wildes JE, Kamarck ML. Prevalence and correlates of binge eating in seasonal affective disorder. Psychiatry Res. 2014;217(1–2):47–53.PubMedPubMedCentral

66.

Flory R, Ametepe J, Bowers B. A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of Seasonal Affective Disorder. Psychiatry Res. 2010;177(1–2):101–8.PubMed

67.

Roecklein K, Wong P, Ernecoff N, Miller M, Donofry S, Kamarck M, et al. The post illumination pupil response is reduced in seasonal affective disorder. Psychiatry Res. 2013;210(1):150–8.PubMedPubMedCentral

68.

Spoont MR, Depue RA, Krauss SS. Dimensional measurement of seasonal variation in mood and behavior. Psychiatry Res. 1991;39(3):269–84.PubMed

69.

Williams JBW. A sructured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45:742–7.PubMed

70.

Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47(2):343–52.PubMed

71.

Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: The Guilford Press; 1979.

72.

Blackburn I-M, James IA, Milne DL, Baker C, Standart S, Garland A, et al. The revised cognitive therapy scale (CTS-R): psychometric properties. Behav Cogn Psychother. 2001;29(4):431–46.

73.

SPSS Inc. SPSS 13.0 Brief Guide. Chicago: SPSS Inc; 2004.

74.

SAS Institute. SAS/STAT User’s guide, version 9.1.3. Cary, NC: SAS Institute; 2004.

75.

Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149–60.PubMed

76.

Frigon JY, Laurencelle L. Analysis of covariance: a proposed algorithm. Educ Psychol Meas. 1993;53(1):1–18.

77.

Fillion L, Kohn P, Gagnon P, Wijk MV, Cunningham A. The inventory of recent life experiences for cancer patients (IRLE-C): a decontaminated measure of cancer-based hassles. Psychol Health. 2001;16(4):443–59.

78.

Brugha TS, Cragg D. The list of threatening experiences: the reliability and validity of a brief life events questionnaire. Acta Psychiatr Scand. 1990;82(1):77–81.PubMed

79.

Sun JL, Wu SC, Chang LI, Chiou JF, Chou PL, Lin CC. The relationship between light exposure and sleep, fatigue, and depression in cancer outpatients: test of the mediating effect. Cancer Nurs. 2014;37(5):382–90.PubMed

80.

Oldham MA, Ciraulo DA. Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system. Chronobiol Int. 2014;31(3):305–19.PubMedPubMedCentral

81.

Pail G, Huf W, Pjrek E, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology. 2011;64(3):152–62.PubMed

82.

Terman M, Amira L, Terman JS, Ross DC. Predictors of response and nonresponse to light treatment for winter depression. Am J Psychiatr. 1996;153(11):1423–9.PubMed

83.

Rosenthal NE. Winter Blues: Everything you need to know to beat seasonal affective disorder. 4th ed. New York: The Guilford Press; 2013.

Titel: Moderators of Cognitive Therapy and Bright Light Therapy Effects on Depressive Symptoms in Patients with Breast Cancer
verfasst von: Caroline Desautels
Josée Savard
Hans Ivers
Publikationsdatum: 01.07.2019
Verlag: Springer US
Erschienen in: International Journal of Behavioral Medicine / Ausgabe 4/2019
Print ISSN: 1070-5503
Elektronische ISSN: 1532-7558
DOI: https://doi.org/10.1007/s12529-019-09802-6

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Moderators of Cognitive Therapy and Bright Light Therapy Effects on Depressive Symptoms in Patients with Breast Cancer

Abstract

Background

Methods

Results

Conclusions

Trial registration

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Trial registration

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Type D Personality and Health-Related Quality of Life in Vascular Surgery Patients

Statistical Guideline #1. Avoid Creating Categorical Variables from Continuous Variables

Improvement in 6-min Walk Test Distance Following Treatment for Behavioral Weight Loss and Disinhibited Eating: an Exploratory Secondary Analysis

Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease

Assessing the Relationship Between Implicit and Explicit Evaluations of Fruit and Vegetable Consumption by Cancer Survivors

Syndemic Factors Associated with Safer Sex Efficacy Among Northern and Indigenous Adolescents in Arctic Canada